Literature DB >> 17453606

Treatment strategies for co-occurring ADHD and substance use disorders.

John J Mariani1, Frances R Levin.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common co-occurring mental disorder among patients with substance use disorders (SUD). Clinicians must be cognizant of the complicated nature of diagnosis and treatment of ADHD when comorbid with SUD. Pharmacotherapy remains the mainstay of treatment for ADHD, although complementary psychotherapeutic approaches have been developed. Psychostimulant medications are the most commonly used medications to treat ADHD, but many clinicians are reluctant to prescribe stimulants to patients with SUD. Recommendations for treatment planning and clinical management for patients with co-occurring ADHD and SUD are discussed.

Entities:  

Mesh:

Year:  2007        PMID: 17453606      PMCID: PMC2676785          DOI: 10.1080/10550490601082783

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  99 in total

1.  Pilot randomized double blind placebo-controlled study of dexamphetamine for cocaine dependence.

Authors:  James Shearer; Alex Wodak; Ingrid van Beek; Richard P Mattick; John Lewis
Journal:  Addiction       Date:  2003-08       Impact factor: 6.526

2.  Accuracy of adult recall of childhood attention deficit hyperactivity disorder.

Authors:  Salvatore Mannuzza; Rachel G Klein; Donald F Klein; Abrah Bessler; Patrick Shrout
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

Review 3.  Assessment and management of attention-deficit hyperactivity disorder in adults.

Authors:  Margaret Weiss; Candice Murray
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

Review 4.  Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD.

Authors:  Nora D Volkow; James M Swanson
Journal:  Am J Psychiatry       Date:  2003-11       Impact factor: 18.112

5.  Psychotherapy of attention deficit hyperactivity disorder in adults--a pilot study using a structured skills training program.

Authors:  Bernd Hesslinger; Ludger Tebartz van Elst; Elisabeth Nyberg; Petra Dykierek; Harald Richter; Michael Berner; Dieter Ebert
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2002-08       Impact factor: 5.270

6.  A pharmacokinetic/pharmacodynamic study comparing a single morning dose of adderall to twice-daily dosing in children with ADHD.

Authors:  Laurence L Greenhill; James M Swanson; Ken Steinhoff; Jane Fried; Kelly Posner; Marc Lerner; Sharon Wigal; Susan B Clausen; Yuxin Zhang; Simon Tulloch
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2003-10       Impact factor: 8.829

7.  Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.

Authors:  Nahit Motavalli Mukaddes; Osman Abali
Journal:  Psychiatry Clin Neurosci       Date:  2004-02       Impact factor: 5.188

8.  Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD.

Authors:  Brooke S G Molina; William E Pelham
Journal:  J Abnorm Psychol       Date:  2003-08

9.  Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies.

Authors:  David Michelson; Lenard Adler; Thomas Spencer; Frederick W Reimherr; Scott A West; Albert J Allen; Douglas Kelsey; Joachim Wernicke; Anthony Dietrich; Denái Milton
Journal:  Biol Psychiatry       Date:  2003-01-15       Impact factor: 13.382

10.  Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature.

Authors:  Timothy E Wilens; Stephen V Faraone; Joseph Biederman; Samantha Gunawardene
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

View more
  27 in total

Review 1.  A review of OROS methylphenidate (Concerta(®)) in the treatment of attention-deficit/hyperactivity disorder.

Authors:  Martin A Katzman; Tia Sternat
Journal:  CNS Drugs       Date:  2014-11       Impact factor: 5.749

2.  Evaluating the consistency of scales used in adult attention deficit hyperactivity disorder assessment of college-aged adults.

Authors:  Ayman Saleh; Catherine Fuchs; Warren D Taylor; Frances Niarhos
Journal:  J Am Coll Health       Date:  2017-10-13

Review 3.  Pharmacological Treatment of ADHD in Addicted Patients: What Does the Literature Tell Us?

Authors:  Pieter-Jan Carpentier; Frances R Levin
Journal:  Harv Rev Psychiatry       Date:  2017 Mar/Apr       Impact factor: 3.732

4.  Patterns and profiles of methylphenidate use both in children and adults.

Authors:  Vanessa Pauly; Elisabeth Frauger; Magalie Lepelley; Michel Mallaret; Quentin Boucherie; Joëlle Micallef
Journal:  Br J Clin Pharmacol       Date:  2018-04-16       Impact factor: 4.335

5.  An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.

Authors:  Timothy E Wilens; Jefferson B Prince; James Waxmonsky; Robert Doyle; Thomas Spencer; Marykate Martelon; Maggie Evans
Journal:  J ADHD Relat Disord       Date:  2010-04-01

6.  The 2-Year Course of Internet Addiction Among a Japanese Adolescent Psychiatric Clinic Sample with Autism Spectrum Disorder and/or Attention-Deficit Hyperactivity Disorder.

Authors:  Ryuhei So; Kazunori Makino; Tomoya Hirota; Masaki Fujiwara; Kozo Ocho; Shin Ikeda; Shouko Tsubouchi; Masatoshi Inagakip
Journal:  J Autism Dev Disord       Date:  2019-11

7.  Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder: a meta-regression analysis.

Authors:  Xavier Castells; Josep Antoni Ramos-Quiroga; David Rigau; Rosa Bosch; Mariana Nogueira; Xavier Vidal; Miguel Casas
Journal:  CNS Drugs       Date:  2011-02       Impact factor: 5.749

8.  Formulation and evaluation of 4-benzylpiperidine drug-in-adhesive matrix type transdermal patch.

Authors:  Sindhu S Ganti; Sonalika A Bhattaccharjee; Kevin S Murnane; Bruce E Blough; Ajay K Banga
Journal:  Int J Pharm       Date:  2018-08-17       Impact factor: 5.875

Review 9.  European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD.

Authors:  Sandra J J Kooij; Susanne Bejerot; Andrew Blackwell; Herve Caci; Miquel Casas-Brugué; Pieter J Carpentier; Dan Edvinsson; John Fayyad; Karin Foeken; Michael Fitzgerald; Veronique Gaillac; Ylva Ginsberg; Chantal Henry; Johanna Krause; Michael B Lensing; Iris Manor; Helmut Niederhofer; Carlos Nunes-Filipe; Martin D Ohlmeier; Pierre Oswald; Stefano Pallanti; Artemios Pehlivanidis; Josep A Ramos-Quiroga; Maria Rastam; Doris Ryffel-Rawak; Steven Stes; Philip Asherson
Journal:  BMC Psychiatry       Date:  2010-09-03       Impact factor: 3.630

10.  Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial.

Authors:  Frances R Levin; John J Mariani; Alex Secora; Daniel Brooks; Wendy Y Cheng; Adam Bisaga; Edward Nunes; Efrat Aharonovich; Wilfrid Raby; Grace Hennessy
Journal:  J Dual Diagn       Date:  2009-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.